Web Analysis for Adaptivebiopharmasolutions - adaptivebiopharmasolutions.com

2.52 Rating by CuteStat

adaptivebiopharmasolutions.com is 6 years 7 months old. It is a domain having com extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, adaptivebiopharmasolutions.com is SAFE to browse.

PageSpeed Score
51
Siteadvisor Rating
Not Applicable

Traffic Report

Daily Unique Visitors: Not Applicable
Daily Pageviews: Not Applicable

Estimated Valuation

Income Per Day: $ 0.15
Estimated Worth: $ 8.95

Search Engine Indexes

Google Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Not Applicable
WOT Child Safety: Not Applicable

Website Ranks & Scores

Alexa Rank: Not Applicable
Domain Authority: Not Applicable

Web Server Information

Hosted IP Address:

88.208.252.9

Hosted Country:

United Kingdom GB

Location Latitude:

51.4964

Location Longitude:

-0.1224
Page Title of adaptivebiopharmasolutions.com
Olexacon
Meta Keywords of adaptivebiopharmasolutions.com
training, medical information, clinical trials, cds, portfolio management, site, market research, project management, portfolio, gi, consultancy, drug development, lean, life sciences, cardiovascular, advantage, marketing strategy, oncology, cns, due diligence, queries, icf, acquisitions, gastroenterology, toxicology, phase 2, phase 3, phase 1, pharmaceutical solutions, medical marketing, biotech, safety database, competitive advantage, six sigma, reimbursement, investigator, crf, site selection, patient engagement, patient safety, payer, literature search, regulatory authority, msl, candidate selection, psmf, feasibility, drug safety, lean six sigma, literature review, central nervous system, dmcs, medical writing, clinical development, quality standards, phase i, 6 sigma, portfolio evaluation, pharmacovigilance, phase 4, risk management plan, case assessment, medical monitor, health technology assessment, advisory boards, phase ii, social media representation, phase iii, protocol development, phase iv, payor, uspi, medical monitoring, medical support, periodic reporting, signal detection, safety reporting, medical review, safety monitoring, translational science, summary of product characteristics, medical affairs, regulatory expectations, advantageous, clinical study report, psur, medwatch, pharmacovigilance database, safety pharmacology, clinical study design, impd, common technical document, investigational medicinal product dossier, pharmaceutical consultancy, key opinion leaders, risk management plans, qppv, investigator brochure, target product profile, cioms, signal validation, signal assessment, signal workup, discussion document, compound development, medical science liaisons, clinical protocol, investigators brochure, clinical study protocol, qualified person for pharmacovigilance, final signatory, safety specifications, translational safety, investigator selection, clinical development plan, monitoring plan, submission documents, investigators meeting, investigators training, data safety monitoring boards, dsmbs, and data monitoring committees, development safety update report, dsur, periodic safety update report, pbrer, periodic benefit risk evaluation report, safety reporting process, identification of susars, susar identification, analysis of similar events, cioms reports, medwatch reports, distribution of safety reports, pharmacovigilance system, designation of qualified person for pharmacovigilance, pharmacovigilance system master file, safety sections of common technical document, safety reference information, united states patient informetion, united states package insert, core data sheet, clinical safety findings, safety findings, regulatory interactions, raise queries, generate queries, initial safety reports, marketing potential, acquisitions opportunities, abpi signatory, health technology appraisal, cancer drugs fund, patient support programs, engagement of patient groups

Page Resources Breakdown

Homepage Links Analysis

Website Inpage Analysis

H1 Headings: 1 H2 Headings: 4
H3 Headings: 1 H4 Headings: 1
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 10
Google Adsense: Not Applicable Google Analytics: Not Applicable

Websites Hosted on Same IP (i.e. 88.208.252.9)

Football Bet Data and Odds | Historical Football Results | Create a Be
- football-bet-data.co.uk
Not Applicable $ 8.95

Football Ramble Daily | Stakhanov
- thefootballramble.com

Football Ramble Daily is a must-listen for any discerning fan that enjoys the more entertaining side of the world’s favourite sport - broadcasting six days a week during the football season!

Not Applicable $ 8.95

Sophia Kemp Illustration
- sophiakemp.co.uk
Not Applicable $ 8.95

Home - Simon Coulson
- simon-coulson.com

Simon Coulson climbed the corporate ladder with BT PLC for 14 years before quitting the city life. He started a series of internet businesses.

Not Applicable $ 8.95

Jobs & Careers | Generic Domain Names For Sale
- onlinemarketingjobs.com
Not Applicable $ 8.95

HTTP Header Analysis

HTTP/1.1 200 OK
Server: openresty
Date: Wed, 30 Aug 2017 23:36:43 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
BKREF: A0-5A
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
P3P: CP="NOI ADM DEV PSAi COM NAV OUR OTR STP IND DEM"
Content-Encoding: gzip
Vary: Accept-Encoding
Age: 0
X-Cache: MISS
X-BKSrc: 0.2
Accept-Ranges: bytes

Domain Information

Domain Registrar: Tucows Domains Inc
Registration Date: Aug 29, 2017, 12:00 AM 6 years 7 months 2 weeks ago
Last Modified: Aug 29, 2017, 12:00 AM 6 years 7 months 2 weeks ago
Domain Status:
clientTransferProhibited
clientUpdateProhibited

Domain Nameserver Information

Host IP Address Country
ns1.livedns.co.uk 217.160.81.244 Germany Germany
ns2.livedns.co.uk 217.160.82.244 Germany Germany
ns3.livedns.co.uk 185.132.35.244 Germany Germany

DNS Record Analysis

Host Type TTL Extra
adaptivebiopharmasolutions.com A 2526 IP: 88.208.252.9
adaptivebiopharmasolutions.com NS 3599 Target: ns3.livedns.co.uk
adaptivebiopharmasolutions.com NS 3599 Target: ns2.livedns.co.uk
adaptivebiopharmasolutions.com NS 3599 Target: ns1.livedns.co.uk
adaptivebiopharmasolutions.com SOA 3599 MNAME: ns1.livedns.co.uk
RNAME: admin.adaptivebiopharmasolutions.com
Serial: 1503346844
Refresh: 10800
Retry: 3600
Expire: 604800
Minimum TTL: 3600
adaptivebiopharmasolutions.com MX 3599 Priority: 10
Target: mailserver.adaptivebiopharmasolutions.com

Full WHOIS Lookup

Domain Name: ADAPTIVEBIOPHARMASOLUTIONS.COM
Registry Domain ID: 2158003660_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucowsdomains.com
Updated Date: 2017-08-29T22:16:58Z
Creation Date: 2017-08-29T22:16:57Z
Registry Expiry Date: 2019-08-29T22:16:57Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.LIVEDNS.CO.UK
Name Server: NS2.LIVEDNS.CO.UK
Name Server: NS3.LIVEDNS.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-30T23:36:30Z
Top Websites • CuteStat Lite Tutorials • Privacy Policy • CuteStat Bot • Update or Remove • Contact Us • What is My IP • Customer Login
Copyright © 2009 - 2024 CuteStat, All Rights Reserved.
Any other brand information used from us are the properties of their respective owners.